SEATTLE GENETICS INC Contracts & Agreements

Agreement and Plan of Merger, dated March 12, 2023, by and among Seagen Inc., Pfizer Inc. and Aris Merger Sub, Inc (Filed With SEC on March 13, 2023)

Voting Agreement, dated March 12, 2023, by and among Seagen Inc., Pfizer Inc., and Baker Bros. Advisors LP, on behalf of itself and certain specified persons identified therein in... (Filed With SEC on March 13, 2023)

Form of Letter Agreement, dated March 12, 2023 (Filed With SEC on March 13, 2023)

Thirteenth Amendment to Development and Supply Agreement, effective May 12, 2022 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and AbbVie Inc. (formerly part of Abbott... (Filed With SEC on July 28, 2022)

Amendment No. 1 to Commercial Supply Agreement dated June 17, 2022 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and Corden Pharma GmbH (Filed With SEC on July 28, 2022)

Form of Stock Unit Grant Notice and Stock Unit Agreement for Non-employee Directors under the Amended and Restated 2007 Equity Incentive Plan (Approved February 10, 2022) (Filed With SEC on April 28, 2022)

Form of Stock Option Agreement for Non-Employee Directors under the Amended and Restated 2007 Equity Incentive Plan (Approved February 10, 2022) (Filed With SEC on April 28, 2022)

Collaboration and License Agreement dated January 7, 2007 between (Filed With SEC on February 9, 2022)

Tenth Amendment to Development and Supply Agreement, effective as of December 26, 2016 between (Filed With SEC on February 9, 2022)

Amended and Restated Employment Agreement dated (Filed With SEC on February 9, 2022)

Amended and Restated Employment Agreement dated February 9, 2022, between Seagen Inc. and (Filed With SEC on February 9, 2022)

Amended and Restated Employment Agreement dated (Filed With SEC on February 9, 2022)

Amended and Restated Employment Agreement dated February 9, 2022, between Seagen Inc. and Todd Simpson (Filed With SEC on February 9, 2022)

Form of Performance-Based Stock Unit Grant Notice and Stock Unit Agreement under the Amended and Restated 2007 Equity Incentive Plan (approved January 18, 2022) (Filed With SEC on February 9, 2022)

Ninth Amendment to Development and Supply Agreement effective as of August 28, 2016 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and AbbVie Inc. (formerly part of Abbott... (Filed With SEC on October 28, 2021)

Commercial Supply Agreement between Hovione Farmaciencia, SA and Seagen Inc. dated July 1, 2021 (Filed With SEC on October 28, 2021)

Form of Performance-Based Stock Unit Grant Notice and Stock Unit Agreement for employees under the Amended and Restated 2007 Equity Incentive Plan (approved August 16, 2021) (Filed With SEC on October 28, 2021)

Form of Stock Option Agreement for U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved August 16, 2021) (Filed With SEC on October 28, 2021)

Form of Stock Option Agreement for Non-U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved August 16, 2021) (Filed With SEC on October 28, 2021)

Form of Stock Unit Grant Notice and Stock Unit Agreement for U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved August 16, 2021) (Filed With SEC on October 28, 2021)

Form of Stock Unit Grant Notice and Stock Unit Agreement for Non-U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved August 16, 2021) (Filed With SEC on October 28, 2021)

License Agreement dated as of August 8, 2021 between RemeGen Co., Ltd. and Seagen Inc (Filed With SEC on September 21, 2021)

Amendment to Joint Commercialization Agreement between Seagen Inc. and Agensys, Inc. effective January 1, 2020 (Filed With SEC on July 29, 2021)

Letter Agreement Regarding Royalty between the University of Miami and Seagen Inc. (f/k/a (Filed With SEC on July 29, 2021)

Lease Agreement dated June 21, 2021 between Seagen Inc. and DPIF2 WA 7 Mountain View, LLC (Filed With SEC on July 29, 2021)

Office lease dated May 9, 2011 between Seagen Inc. (f/k/a Seattle Genetics Inc.) and WCM Highlands II LLC (Filed With SEC on April 29, 2021)

Third Amendment to Lease dated May 9, 2011 between Seagen Inc. (f/k/a Seattle Genetics Inc.) and B&N 141-302, LLC (Filed With SEC on April 29, 2021)

Amended and Restated 2000 Employee Stock Purchase Plan, effective March 12, 2021 (Filed With SEC on April 29, 2021)

Form of Stock Option Agreement for U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved March 8, 2021) (Filed With SEC on April 29, 2021)

Form of Stock Option Agreement for Non-U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved March 8, 2021) (Filed With SEC on April 29, 2021)

Form of Stock Option Agreement for Non-Employee Directors under the Amended and Restated 2007 Equity Incentive Plan (approved March 8, 2021) (Filed With SEC on April 29, 2021)

Form of Time-Based Stock Unit Grant Notice and Stock Unit Agreement for U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved March 8, 2021) (Filed With SEC on April 29, 2021)

Form of Stock Unit Grant Notice and Stock Unit Agreement for Non-U.S. Participants under the Amended and Restated 2007 Equity Incentive Plan (approved March 8, 2021) (Filed With SEC on April 29, 2021)

Form of Stock Unit Grant Notice and Stock Unit Agreement for French Grantees under the Amended and Restated 2007 Equity Incentive Plan (approved March 8,2021) (Filed With SEC on April 29, 2021)

Form of Stock Unit Grant Notice and Stock Unit Agreement for non-employee directors under the Amended and Restated 2007 Equity Incentive Plan (approved March 8, 2021) (Filed With SEC on April 29, 2021)

Specimen Stock Certificate (Filed With SEC on February 12, 2021)

Joint Commercialization Agreement dated October 19, 2020 between Genmab A/S and Seagen Inc. (f.k.a. Seattle Genetics Inc.) (Filed With SEC on February 12, 2021)

Commercial Supply Agreement dated December 1, 2010 between (Filed With SEC on February 12, 2021)

First Amendment to Commercial Supply Agreement effective as of January 20, 2014 between (Filed With SEC on February 12, 2021)

Second Amendment to Commercial Supply Agreement effective as of December 2, 2016 between (Filed With SEC on February 12, 2021)

Sixth Amendment to Development and Supply Agreement dated November 18, 2010 between (Filed With SEC on February 12, 2021)

Senior Executive Annual Bonus Plan, as amended February 9, 2021 (Filed With SEC on February 12, 2021)

License and Collaboration Agreement relating to ladiratuzumab vedotin dated September 13, 2020 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and Merck Sharp & Dohme Corp (Filed With SEC on October 30, 2020)

Stock Purchase Agreement dated September 13, 2020 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and Merck Sharp & Dohme Corp (Filed With SEC on October 30, 2020)

Form of Performance-Based Stock Unit Grant Notice and Stock Unit Agreement under the (Filed With SEC on October 30, 2020)

Commercial Supply Agreement dated June 13, 2019 between Seattle Genetics, Inc. and Esteve Quimica, S.A (Filed With SEC on July 31, 2020)

Amendment No. 1 (Filed With SEC on July 31, 2020)

Commercial Supply Agreement dated February 20, 2020 between Seattle Genetics, Inc. and Corden Plankstadt (Filed With SEC on July 31, 2020)

Commercial Supply Agreement dated April 2, 2020 between Seattle Genetics, Inc. and Sterling Pharma Solutions Limited (Filed With SEC on July 31, 2020)

Amendment No. 1 to License Agreement dated April 23, 2020 between Cascadian Therapeutics, Inc. and Array BioPharma, Inc (Filed With SEC on July 31, 2020)

Seattle Genetics, Inc. Equity Incentive Plan, effective as of May 15, 2020 (Filed With SEC on July 31, 2020)

Amended and Restated Employment Agreement dated April 15, 2020 between Seattle Genetics, Inc. and Charles Romp (Filed With SEC on July 31, 2020)

Form of Stock Option Agreement for U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved March 13, 2020) (Filed With SEC on April 30, 2020)

Form of Stock Option Agreement for Non-U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved March 13, 2020) (Filed With SEC on April 30, 2020)

Rules of the Seattle Genetics Inc. Amended and Restated 2007 Equity Incentive Plan for Restricted Stock Unit Awards Granted to French Grantees effective as of March 13, 2020 (Filed With SEC on April 30, 2020)

Form of Stock Unit Grant Notice and Stock Unit Agreement for French Grantees under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved March 13,... (Filed With SEC on April 30, 2020)

Description of Securities of Seattle Genetics, Inc (Filed With SEC on February 6, 2020)

Eleventh Amendment to Development and Supply Agreement effective July 12, 2018 between Seattle Genetics, Inc. and AbbVie Inc. (formerly part of Abbott Laboratories, Inc.) (Filed With SEC on February 6, 2020)

Form of Stock Option Agreement for U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved December 19, 2019) (Filed With SEC on February 6, 2020)

Form of Stock Option Agreement for Non-US Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved December 19, 2019) (Filed With SEC on February 6, 2020)

Form of Time-Based Stock Unit Grant Notice and Stock Unit Agreement for employees under Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved December... (Filed With SEC on February 6, 2020)

Form of Stock Unit Grant Notice and Stock Unit Agreement for non-US Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved... (Filed With SEC on February 6, 2020)

Form of Performance-Based Stock Unit Agreement for U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved December 19, 2019) (Filed With SEC on February 6, 2020)

Form of Stock Unit Grant Notice for US Participants Long Term Incentive Plan for EV and TV (approved December 19, 2019) (Filed With SEC on February 6, 2020)

Form of Stock Unit Grant Notice for Non-US Participants Long Term Incentive Plan for EV and TV (approved December 19, 2019) (Filed With SEC on February 6, 2020)

Form of Performance-Based Stock Unit Notice and Stock Unit Agreement for U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan... (Filed With SEC on February 6, 2020)

Form of Performance-Based Stock Unit Notice and Stock Unit Agreement for Non-U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan... (Filed With SEC on February 6, 2020)

Collaboration Agreement between Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc. (a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited) dated December 14,... (Filed With SEC on February 6, 2020)

Form of Performance-Based Stock Unit Grant Notice and Stock Unit Agreement under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved August 26,... (Filed With SEC on October 30, 2019)

Third Amendment to Commercial Supply Agreement effective as of July 1, 2019 between Seattle Genetics, Inc. and SAFC, an operating division of Sigma-Aldrich, Inc (Filed With SEC on October 30, 2019)

Twelfth Amendment to Development and Supply Agreement, effective as of April 25, 2019 between Seattle Genetics, Inc. and AbbVie, Inc. (formerly part of Abbott Laboratories, Inc.) (Filed With SEC on July 16, 2019)

Employment Agreement, dated May 20, 2019, between Seattle Genetics, Inc. and Robin Taylor (Filed With SEC on July 16, 2019)

Joint Commercialization Agreement dated October 20, 2018 between Seattle Genetics, Inc. and Agensys, Inc (Filed With SEC on July 16, 2019)

Seattle Genetics, Inc. Senior Executive Annual Bonus Plan, effective February 4, 2019 (Filed With SEC on February 7, 2019)

Amended and Restated Employment Agreement dated October 25, 2018, between Seattle Genetics, Inc. and Clay Siegall (Filed With SEC on October 26, 2018)

Amended and Restated Employment Agreement dated October 25, 2018, between Seattle Genetics, Inc. and Todd Simpson (Filed With SEC on October 26, 2018)

Amended and Restated Employment Agreement dated October 25, 2018, between Seattle Genetics, Inc. and Roger Dansey (Filed With SEC on October 26, 2018)

Amended and Restated Employment Agreement dated October 25, 2018, between Seattle Genetics, Inc. and Vaughn Himes (Filed With SEC on October 26, 2018)

Amended and Restated Employment Agreement dated October 25, 2018, between Seattle Genetics, Inc. and Darren Cline (Filed With SEC on October 26, 2018)

Amended and Restated Employment Agreement dated October 25, 2018, between Seattle Genetics, Inc. and Jean Liu (Filed With SEC on October 26, 2018)

Seattle Genetics, Inc. Long Term Incentive Plan for Tucatinib (Filed With SEC on October 26, 2018)

Form of Stock Option Agreement for U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved August 30, 2018) (Filed With SEC on October 26, 2018)

Form of Stock Option Agreement for non-US Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved August 30, 2018) (Filed With SEC on October 26, 2018)

Form of Performance-Based Stock Unit Agreement for U.S. Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved August 30, 2018) (Filed With SEC on October 26, 2018)

Form of Stock Unit Grant Notice and Stock Unit Agreement for US Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved October 24,... (Filed With SEC on October 26, 2018)

Form of Stock Unit Grant Notice and Stock Unit Agreement for non-US Participants under the Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (approved October... (Filed With SEC on October 26, 2018)

Compensation Information for Executive Officers (Filed With SEC on October 26, 2018)

Employment Agreement, dated May 31, 2018, between Seattle Genetics, Inc. and Roger Dansey (Filed With SEC on July 26, 2018)

Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan, effective as of May 18, 2018 (Filed With SEC on July 26, 2018)

Form of Notice of Stock Option Grant and Stock Option Agreement for non-employee directors under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on July 26, 2018)

Form of Stock Unit Grant Notice and Stock Unit Agreement for non-employee directors under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on July 26, 2018)

Form of Stock Option Agreement for Non-US Participants under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on July 26, 2018)

Form of Stock Unit Grant Notice and Stock Unit Agreement for non-US participants under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on July 26, 2018)

Form of Performance-Based Stock Option Agreement for employees under Seattle Genetics, Inc. 2007 Equity Incentive Plan (Filed With SEC on July 26, 2018)

Form of Time-Based Stock Option Agreement for employees under Seattle Genetics, Inc. 2007 Equity Incentive Plan (Filed With SEC on July 26, 2018)

Form of Performance-Based Stock Unit Grant Notice and Stock Unit Agreement for employees under Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on July 26, 2018)

Form of Time-Based Stock Unit Grant Notice and Stock Unit Agreement for employees under Seattle Genetics, Inc. Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on July 26, 2018)

License Agreement between Cascadian Therapeutics, Inc. and Array BioPharma Inc. dated December 11, 2014 (Filed With SEC on April 26, 2018)

Fourth Amendment to Lease dated October 24, 2017 between Seattle Genetics, Inc. and SNH Medical Office Properties Trust, as successor in interest to B&N 141-302, LLC (Filed With SEC on February 15, 2018)

First Amendment to Office Lease dated October 24, 2017 between Seattle Genetics, Inc. and SNH Medical Office Properties Trust, as successor in interest to WCM Highlands II, LLC (Filed With SEC on February 15, 2018)

Compensation Information for Executive Officers and Directors (Filed With SEC on February 15, 2018)

Underwriting Agreement, dated January 31, 2018, by and between Seattle Genetics, Inc. and Barclays Capital Inc. and J.P. Morgan Securities LLC, as representatives of the several... (Filed With SEC on February 1, 2018)

Agreement and Plan of Merger, dated as of January 30, 2018, by and among Seattle Genetics, Inc., Valley Acquisition Sub, Inc. and Cascadian Therapeutics, Inc (Filed With SEC on January 31, 2018)

Commitment Letter, dated as of January 30, 2018, with Barclays Bank PLC and JPMorgan Chase Bank, N.A (Filed With SEC on January 31, 2018)

Asset Purchase Agreement, dated July 31, 2017, between Bristol-Myers Squibb Company and Seattle Genetics, Inc (Filed With SEC on November 6, 2017)

Purchase Agreement, dated June 16, 2017, between BMR-3450 Monte Villa Parkway, LLC and ZymoGenetics, Inc (Filed With SEC on November 6, 2017)

Assignment and Assumption of Purchase Agreement, dated July 30, 2017, between ZymoGenetics, Inc. and Seattle Genetics, Inc (Filed With SEC on November 6, 2017)

License and Collaboration Agreement, effective October 7, 2011, between Genmab A/S and Seattle Genetics, Inc (Filed With SEC on November 6, 2017)

Seattle Genetics, Inc. Long Term Incentive Plan for TV and EV (Filed With SEC on November 6, 2017)

Form of Stock Unit Grant Notice for Long Term Incentive Plan for TV and EV (Filed With SEC on November 6, 2017)

Form Stock Unit Grant Notice for Non-US Participants Long Term Incentive Plan for TV and EV (Filed With SEC on November 6, 2017)

Termination Agreement, dated May 4, 2017, between Immunomedics, Inc. and Seattle Genetics, Inc (Filed With SEC on August 1, 2017)

DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on May 1, 2017)

STOCKPURCHASE AGREEMENT (Filed With SEC on May 1, 2017)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on May 1, 2017)

Warrant Certificate (Filed With SEC on May 1, 2017)

WARRANTAGREEMENT (Filed With SEC on May 1, 2017)

Amendment to SGD-1006 Commercial Supply Agreement executed on 1 December 2010. [*] Manufacturing Controls Price Increase (Filed With SEC on February 21, 2017)

Second Amendmentto SGD-1006 Commercial Supply Agreement executed on 1 December 2010 and First Amendment to Commercial Supply Agreement executed on 20 January 2014 (the First... (Filed With SEC on February 21, 2017)

TENTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on February 21, 2017)

SEATTLE GENETICS, INC. AMENDED AND RESTATED 2000 EMPLOYEE STOCK PURCHASE PLAN Adopted by the Board of Directors: November 16, 2000 Approved by the Stockholders: February 14, 2001... (Filed With SEC on February 21, 2017)

SEATTLE GENETICS, INC. Senior Executive Annual Bonus Plan (Filed With SEC on February 1, 2017)

NINTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on October 27, 2016)

SEATTLE GENETICS, INC. LONG TERM INCENTIVE PLAN FOR SGN-CD33A (Filed With SEC on October 27, 2016)

SEATTLE GENETICS, INC. STOCK UNIT GRANT NOTICE (AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN) (Filed With SEC on October 27, 2016)

AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 27, 2016)

21823 - 30th DriveSoutheast Bothell, Washington 98021 Tel ###-###-#### Fax ###-###-#### www.seattlegenetics.com (Filed With SEC on July 26, 2016)

SEATTLE GENETICS, INC. LONG TERM INCENTIVE PLAN FOR ECHELON-1 Effective Date: May 9, 2016 (Filed With SEC on July 26, 2016)

SEATTLE GENETICS, INC. AMENDED & RESTATED 2007 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on July 26, 2016)

SEATTLE GENETICS, INC. AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN (amended and restated by the Board August 5, 2009) (amended and restated by the Board March 11, 2010)... (Filed With SEC on July 26, 2016)

21823 - 30th Drive Southeast Bothell, Washington98021 Tel: 425 ###-###-#### Fax: 425 ###-###-#### www.seattlegenetics.com (Filed With SEC on February 19, 2016)

SEATTLE GENETICS, INC. 2016 Senior Executive Annual Bonus Plan (Filed With SEC on January 29, 2016)

UNDERWRITING AGREEMENT SEATTLEGENETICS, INC. 11,707,318 Shares of Common Stock Underwriting Agreement (Filed With SEC on September 11, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 11, 2015)

EIGHTH AMENDMENT TODEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on July 30, 2015)

SEATTLE GENETICS, INC. DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on February 27, 2015)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 27, 2015)

SEATTLE GENETICS, INC. 2015 Senior Executive Annual Bonus Plan (Filed With SEC on February 6, 2015)

SEATTLE GENETICS, INC. AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN (amended and restated by the Board August 5, 2009) (amended andrestated by the Board March 11, 2010)... (Filed With SEC on August 8, 2014)

SEATTLE GENETICS, INC. STOCK UNIT GRANT NOTICE (AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN) (Filed With SEC on February 28, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 28, 2014)

SEATTLE GENETICS, INC. 2014 Senior Executive Annual Bonus Plan (Filed With SEC on February 28, 2014)

SEATTLE GENETICS, INC. 2013 Senior Executive Annual Bonus Plan (Filed With SEC on February 27, 2013)

SEVENTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on February 27, 2013)

APPENDIX A SEATTLE GENETICS, INC. AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN Amended and Restated by the Board of Directors: August 5, 2009 Amended and Restated by the Board... (Filed With SEC on August 8, 2012)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 8, 2012)

SEATTLE GENETICS, INC. SEVERANCE AND RELEASE AGREEMENT (Filed With SEC on February 23, 2012)

SEATTLE GENETICS, INC. 2012 Senior Executive Annual Bonus Plan (Filed With SEC on February 23, 2012)

COMMERCIAL SUPPLY AGREEMENT SGD-1006 (Filed With SEC on November 4, 2011)

SECOND AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on November 4, 2011)

THIRD AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on November 4, 2011)

FOURTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on November 4, 2011)

FIFTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on November 4, 2011)

SIXTH AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on November 4, 2011)

SEATTLE GENETICS, INC. STOCK UNIT GRANT NOTICE (AMENDED AND RESTATED 2007 EQUITY INCENTIVEPLAN) (Filed With SEC on August 30, 2011)

OFFICE LEASE (Filed With SEC on August 5, 2011)

THIRD AMENDMENT TO LEASE (Filed With SEC on August 5, 2011)

SEATTLE GENETICS, INC. AMENDED AND RESTATED 2000 EMPLOYEE STOCKPURCHASE PLAN Adopted by the Board of Directors: November 16, 2000 Approved by the Stockholders: February 14, 2001... (Filed With SEC on August 5, 2011)

SEATTLE GENETICS, INC. AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on August 5, 2011)

SEATTLE GENETICS, INC. AMENDED AND RESTATED 2000 EMPLOYEE STOCKPURCHASE PLAN Adopted by the Board of Directors: November 16, 2000 Approved by the Stockholders: February 14, 2001... (Filed With SEC on February 28, 2011)

SEATTLE GENETICS, INC. 2011 Senior Executive Annual Bonus Plan (Filed With SEC on February 16, 2011)

10,000,000 Shares SEATTLE GENETICS, INC. Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT February 2, 2011 (Filed With SEC on February 2, 2011)

SEATTLE GENETICS, INC. 2000 DIRECTORS STOCK OPTION PLAN (as amended February 5,2010) (Filed With SEC on March 12, 2010)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2010)

AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on March 12, 2010)

ARTICLE 1 (Filed With SEC on March 12, 2010)

SEATTLE GENETICS, INC. LONG TERM INCENTIVE PLAN Effective Date: March 11, 2010 (Filed With SEC on March 12, 2010)

SEATTLE GENETICS, INC. 2010 Senior ExecutiveAnnual Bonus Plan (Filed With SEC on February 12, 2010)

SEATTLE GENETICS, INC. 11,000,000 Shares of Common Stock (Filed With SEC on August 12, 2009)

SEATTLE GENETICS, INC. AMENDED AND RESTATED (Filed With SEC on August 10, 2009)

SEATTLE GENETICS, INC. 2007 EQUITY INCENTIVE PLAN (Filed With SEC on March 13, 2009)

AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2009)

OPTION and LICENSE AGREEMENT (Filed With SEC on March 13, 2009)

AMENDMENT NO. 1 TO (Filed With SEC on March 13, 2009)

Consulting Agreement (Filed With SEC on March 13, 2009)

SEATTLE GENETICS, INC. 5,740,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on January 28, 2009)

among SEATTLE GENETICS, INC and THE INVESTORS NAMED HEREIN Dated as of July 8, 2003 TABLE OF CONTENTS (Filed With SEC on November 7, 2008)

SECOND AMENDMENT TO LEASE (Filed With SEC on November 7, 2008)

COLLABORATION AGREEMENT (Filed With SEC on November 7, 2008)

FIRST AMENDMENT (Filed With SEC on August 8, 2008)

AMENDMENT No. 1 (Filed With SEC on August 8, 2008)

SEATTLE GENETICS, INC. 2008 Senior Executive Annual Bonus Plan (Filed With SEC on February 4, 2008)

J.P. MORGAN SECURITIES INC. FORM OF UNDERWRITING AGREEMENT (Filed With SEC on January 18, 2008)

SEATTLE GENETICS, INC. SEVERANCE AND RELEASE AGREEMENT (Filed With SEC on June 1, 2007)

COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on May 8, 2007)

COLLABORATION AGREEMENT (Filed With SEC on May 8, 2007)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 9, 2007)

SEATTLE GENETICS, INC. 2007 Senior Executive Annual Bonus Plan (Filed With SEC on January 24, 2007)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on September 8, 2006)

AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on September 8, 2006)

BIOPHARMACEUTICAL MANUFACTURING SERVICES AGREEMENT (Filed With SEC on August 8, 2006)

SEATTLE GENETICS, INC. 1998 STOCK OPTION PLAN (Filed With SEC on May 18, 2006)

SEATTLE GENETICS, INC. Common Stock UNDERWRITING AGREEMENT dated March 29, 2006 Underwriting Agreement (Filed With SEC on March 30, 2006)

SEATTLE GENETICS, INC. 2006 Senior Executive Annual Bonus Plan (Filed With SEC on March 24, 2006)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 21, 2005)

SEATTLE GENETICS, INC. (Filed With SEC on August 23, 2005)

LICENSE AGREEMENT (Filed With SEC on August 9, 2005)

COLLABORATION AGREEMENT (Filed With SEC on August 9, 2005)

MANUFACTURING AND SUPPLY AGREEMENT BETWEEN (Filed With SEC on August 9, 2005)

COLLABORATION AGREEMENT (Filed With SEC on August 9, 2005)

SEATTLE GENETICS, INC. (Filed With SEC on May 18, 2005)

SEATTLE GENETICS, INC. DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on May 10, 2005)

SEATTLE GENETICS, INC. (Filed With SEC on March 15, 2005)

COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on November 10, 2004)

COLLABORATION AGREEMENT by and between SEATTLE GENETICS, INC. (Filed With SEC on November 10, 2004)

AMENDMENT NO. 2 TO COLLABORATION AGREEMENT (Filed With SEC on November 10, 2004)

AMENDMENT NO. 3 TO LICENSE AGREEMENT (Filed With SEC on November 10, 2004)

COLLABORATION AGREEMENT (Filed With SEC on August 10, 2004)

AMENDMENT TO COLLABORATION AGREEMENT BY AND BETWEEN SEATTLE GENETICS, INC. AND PROTEIN DESIGN LABS, INC. (Filed With SEC on May 10, 2004)

PATENT LICENSE AGREEMENT between PROTEIN DESIGN LABS, INC. (Filed With SEC on May 10, 2004)

SEATTLE GENETICS, INC. DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on May 10, 2004)

SEATTLE GENETICS, INC. (Filed With SEC on March 16, 2004)

7,000,000 Shares (Filed With SEC on February 5, 2004)

AMENDMENT NO. 1 TO COLLABORATION AGREEMENT (Filed With SEC on November 12, 2003)

SEVERANCE AND RELEASE AGREEMENT (Filed With SEC on November 12, 2003)

SEATTLE GENETICS, INC. (Filed With SEC on November 12, 2003)

AMENDMENT TO AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT OF SEATTLE GENETICS, INC. (Filed With SEC on August 12, 2003)

RECITAL (Filed With SEC on August 12, 2003)

JOINDER AGREEMENT (Filed With SEC on May 15, 2003)

LICENSE AGREEMENT (Filed With SEC on May 9, 2003)

CONFIDENTIAL NON-EXCLUSIVE CABILLY PATENT LICENSEAGREEMENT [Cabilly Coexpression Patents] (Filed With SEC on May 9, 2003)

COLLABORATIONAGREEMENT (Filed With SEC on August 13, 2002)

SEATTLE GENETICS, INC. 2002 COMMON STOCK PURCHASE AGREEMENT Dated as of April 19, 2002 SEATTLE GENETICS, INC. (Filed With SEC on August 13, 2002)

COLLABORATION AGREEMENT (Filed With SEC on May 14, 2002)

SEATTLEGENETICS, INC. COMMONSTOCK PURCHASE AGREEMENT Dated as of January 4, 2002 SEATTLEGENETICS, INC. Common Stock Purchase Agreement (Filed With SEC on May 14, 2002)

COLLABORATION AGREEMENT (Filed With SEC on May 14, 2002)

CONTRACT MANUFACTURING AGREEMENT (Filed With SEC on November 9, 2001)

2001 Executive Performance Plan (Filed With SEC on November 9, 2001)

COLLABORATION AGREEMENT (Filed With SEC on August 13, 2001)

Category

Industry

Companies

Contracts

SEATTLE GENETICS INC Contracts & Agreements